Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCLG-APL2016 pediatric APL study
ChiCTR-OIN-17011227Phase 4Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Jul 2016
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of tretinoin, arsenic trioxide and Compound Huangdai Tablet in Acute promyelocytic leukaemia (APL) (2 arms), sponsored by Beijing Children's Hospital. Primary endpoints: remission state of hematology, remission state of bone marrow and 3 more. Started Jul 2016; status: recruiting.
02
Drugs
tretinoinarsenic trioxideCompound Huangdai Tablet
03
Conditions
Acute promyelocytic leukaemia (APL)
Beyond the preview
Go deeper on ChiCTR-OIN-17011227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17011227.